Cargando…
The TLR4 Agonist Immunomax Affects the Phenotype of Mouse Lung Macrophages during Respiratory Syncytial Virus Infection
In the study, the effect of the TLR4 agonist Immunomax was investigated in vitro and in vivo. In particular, Immunomax was shown to polarize mouse bone marrow macrophages from the M0 and M2 states into the M1 state (ARG1 and iNOS mRNA expression levels were used to identify the mouse M1 and M2 pheno...
Autores principales: | Nikonova, A. A., Pichugin, A. V., Chulkina, M. M., Lebedeva, E. S., Gaisina, A. R., Shilovskiy, I. P., Ataullakhanov, R. I., Khaitov, M. R., Khaitov, R. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351037/ https://www.ncbi.nlm.nih.gov/pubmed/30713767 |
Ejemplares similares
-
Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer
por: Ghochikyan, Anahit, et al.
Publicado: (2014) -
The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector
por: Lebedeva, Ekaterina, et al.
Publicado: (2018) -
Regulation of the Target Protein (Transgene) Expression in the Adenovirus Vector Using Agonists of Toll-Like Receptors
por: Bagaev, A. V., et al.
Publicado: (2014) -
Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology
por: Shilovskiy, Igor P., et al.
Publicado: (2021) -
The Role of Interleukin-37 in the Pathogenesis of Allergic Diseases
por: Shilovskiy, I. P., et al.
Publicado: (2019)